Literature DB >> 23451328

Assessment of clinical benefit and quality of life in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of peritoneal carcinomatosis.

Maheswari Senthil1.   

Abstract

Entities:  

Year:  2013        PMID： 23451328      PMCID： PMC3562625          DOI： 10.3978/j.issn.2078-6891.2013.001

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  8 in total

1.  Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

Authors:  Jan Franko; Qian Shi; Charles D Goldman; Barbara A Pockaj; Garth D Nelson; Richard M Goldberg; Henry C Pitot; Axel Grothey; Steven R Alberts; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases.

Authors:  Yue Zhu; Nader Hanna; Cherif Boutros; H Richard Alexander
Journal:  J Gastrointest Oncol       Date:  2013-03

3.  A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix.

Authors:  Dominique Elias; Olivier Glehen; Marc Pocard; François Quenet; Diane Goéré; Catherine Arvieux; Patrick Rat; François Gilly
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

4.  Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.

Authors:  Olivier Glehen; François N Gilly; Florent Boutitie; Jean M Bereder; François Quenet; Lucas Sideris; Baudouin Mansvelt; Gérard Lorimier; Simon Msika; Dominique Elias
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

5.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

Authors:  O Glehen; F Kwiatkowski; P H Sugarbaker; D Elias; E A Levine; M De Simone; R Barone; Y Yonemura; F Cavaliere; F Quenet; M Gutman; A A K Tentes; G Lorimier; J L Bernard; J M Bereder; J Porcheron; A Gomez-Portilla; P Shen; M Deraco; P Rat
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

6.  8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Sjoerd Bruin; Henk Boot; Gooike van Slooten; Harm van Tinteren
Journal:  Ann Surg Oncol       Date:  2008-06-03       Impact factor: 5.344

7.  Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis.

Authors:  Joerg O W Pelz; Alexander Stojadinovic; Aviram Nissan; Werner Hohenberger; Jesus Esquivel
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

8.  Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.

Authors:  Y L B Klaver; L H J Simkens; V E P P Lemmens; M Koopman; S Teerenstra; R P Bleichrodt; I H J T de Hingh; C J A Punt
Journal:  Eur J Surg Oncol       Date:  2012-05-08       Impact factor: 4.424
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.